Presenting disease as a percentage of the Total Study Group:

Including Lupus, Allergies, Fibromyalgia, Blood Disorders, Chronic Infections,
Recurrent Infections, Autoimmune Diseases, and Cervical Dysplasia/Metaplasia.
All Study Group participants recorded significantly higher NK cell activity.

Treatment period:

Clinical Study Summary of 107 patients

FULL Clinical Study Report of 107 patients

Biomune OSF Plus™

The potential benefits available through Colostrum and whey are being discussedeverywhere.  Claims of benefit from the consumption of “Pure, CleanColostrum” or “Filtered Whey” are everywhere.  Indeed, the benefit ofbreast-feeding infants has covered magazine racks for years.

Bovine colostum is touted as the “new” source of health.  BovineColostrum is now a commodity.  Buyers and sellers from all over the world are beingbrought together for purpose of creating a new marketable commodity.  New companieshave emerged to sell this commodity in various forms of “after-market”marketing.

Though bovine Colostrum has some demonstrated benefit, by itself bovine Colostrum isnot a silver bullet.  It is simply another commodity like wheat or milk.  Aswith all commodities, all are not created equal and do not contain equal characteristics.Quantum Research, Inc. and Dr. Jesse Stoff have demonstrated that high quality, highlycontrolled extracts can be combined with other nutritional ingredients to createsignificant products that can bring changes in the performance of the immune system.

Quantum Research, Inc. is able to create the amazing extracts used in the products forseveral reasons.

They use a proprietary technology protected by a totally unique and protected patentedprocess.

They utilize a privately managed dairy herd that originated over thirty years ago.

They access nearly forty years of experience in bovine Colostrum collection and study.
Dr. Stoff and Dr. Olsztyn have used these extracts for nearly twenty years in medicalpractice.
 
Biomune OSF Plus‰ utilizes the herb Astragalus in combination with a special extractof dairy Colostrum and whey.  Clinical studies indicate that this combination createsa synergistic effect on the immune system resulting in elevation of NK cell activity.

The herb Astragalus, with the Latin name Astragalus membranaceus, is derived form theroot of this perennial herb which is Chinese in origin and considered a traditionalChinese herb.  Astragalus is considered an immune stimulation herb. The “stemcells” in the bone marrow are increased and their development is stimulated intoactive immune cells that are then released into the body.  Essentially, every phaseof the immune system activity is stimulated by Astragalus.

Active ingredients contained in Astragalus include bioflavanoids, choline, andastragalan B, a polysaccharide.  Astragalan B has been shown in animal studies to beeffective at protecting the body against a number of toxins, controlling bacterialinfections and stimulating the immune system.  Astragalan B appears to work byallowing the body’s immune system to attack the outer membranes of viruses,destabilizing their defenses and allowing them to be overwhelmed by the immune response.

Astragalus increases interferon production and enhances NK and T cell function,increasing resistance to viral conditions.  Astragalus has also been shown to supportthe body in peripheral vascular disease and peripheral circulation.  Astragalus aidsadrenal gland function that often needs support in chronic and degenerative health states.

Researchers in China have conducted recent studies which report that Astragalus is aneffective treatment for supporting the immune system in cancer patients.  Twoseparate studies followed patients receiving traditional chemotherapy and radiationtreatment, which typically devastate the immune system and leave the recipients weak andsusceptible to new opportunistic infections.  Patients receiving Astragalus extractshad twice the survival rate of those only receiving standard therapies.  Furtherstudies in the U.S. confirmed that Astragalus has unique immunity enhancement qualities.
 
Astragalus has been available in China for centuries and has a long history of use intraditional medicine in China.  It is used to strengthen the Wei Ch’i or“denfensive energy”.  It is regarded as a tonic for stimulating the immunesystem and increasing energy levels.  It has also been used as a diuretic and avasodilator for respiratory infections.  It has also been used for colds, flu and toincrease stamina.
 

Clinical Study Summary of 107 patients

FULL Clinical Study Report of 107 patients

REFERENCES

1.  “Purification of transfer factors”, Rosso, S.J. etal, Mol. Immunol. 1992,
     Feb; 29(2): 167-82

2.  Transfer factor is effective across different mammalianspecies.
      “Isolation and purification of HSV-1 specific transferfactor produced by
      HSV-1 immunized goat leukocyte dialysate”  by Dr.Qitly et al, Acta Virol
      1992, May; 36(3): 231-8

3.  Transfer factor is just as effective when taken orally as byinjection.
     “Murine transfer factors: dose-response relationships androutes of
     administration”  Kirk Patrick, C.H., et al, CellImmunol, 1995, Sep;
     164(2):203-6

4.  “Transfer factor presents relapse in herpes keratitispatients; a pilot study”
     Pizza, G. et al, Biotherapy 1994; 8(1): 63-8

5.  “Adjuvant treatment using transfer factor for bronchogeniccarcinoma: long-
     term follow-up”, Whyte, R.I. et al, Arr Thoracic Surgery,1992, Mar; 53(3):
     391-6

6.  “Immunotherapy with transfer factor of recurrent herpessimplex type I”,
     Estranda-Parra, S. et al, Arch Med Res, 1995;26

7.  “Effect of Brucella abortus transfer factor in preventingmurine brucellosis”,
     Stevens, M.G. et al, Immunol Med Microbiol, 1995, Jul; 11(4):279-84

8.  “Transfer factor in malignancy”, Pizza, G. et al,Prog Drug Res  1994; 42:
     401-21

9.  “Specific transfer factor with activity againstEpstein-Barr virus reduces late
     relapse in endemic Burkitt’s lymphoma”, Neequaye, J. etal, Anticancer
     Research 1990 Sept-Oct; 10 (5A): 1183-7

10. “A controlled trial of bovine dialyzable lukocyte extract(transfer factor) for
     cryptosporidiosis in patients with AIDS” McMeeking, A. etal, J. Infect Dis,
     1990 Jan; 161(1): 108-12

11. Clark D, Wyatt K: Colostrum, Life’s First Food.  Salt LakeCity: CNR
     Publications, 1996.

12. Lange S: Immune mechanisms of cardiac disease.  New England Journal
      Of Medicine 330(7): 1129, April 21, 1994.

13. Kohl S, et al: Human colostral cytotoxicity: antibody-dependentcellular
      cytotoxicity against herpes simplex infected cells mediatedby colostral
      cells.  Journal of Clinical Laboratory Immunology1:221-224.

14. Acosta-Altamirano G, et al: Anti-amoebic properties of humanColostrum.
      Adv Exp Med Biol 216B: 1347-1352, 1987.

15. Boesman-Finkelstein M., et al: Passive oral immunization ofchildren.  The
      Lancet. 49:1336, 1989.

16. Haynes BF, Fauci AS: Introduction to clinical immunology. Part II,
      section 2. in: Harrison’s Principles of InternalMedicine, Eleventh
      Edition.  Braunwald E (eds), et al. New York: McGrawHill Book Co,
      Janusz M, et al: Immunoregulatory properties of syntheticpeptides:
      fragments of a proline-rich polypeptide from bovineColostrum.
      Molecular Immunology 24(10): 1029-1031, 1987.

17. Kim K, et al: In vitro and in vivo neutralizing activity of humanColostrum
      and milk against purified toxins A and B of Clostridiumdifficile. T Infect Dis
      150:57-61, 1985.

18. Ogra P, et al: Colostrum derived immunity and maternal neonatal
      interaction.  Annals NY Acad Sci 409:82-92, 1983.

19. Palmer EL, et al: Antiviral activity of Colostrum and serum immuno-
      globulins A and G.  J Med Virol 5:123-129, 1980.

20. Sabirl, AB: Anti-poliomyelitic substance in milk from human beingsand
      certain cows.  T Dis Children 80:866-870, 1950.

21. Spik, G., et al., Bacteriostasis of a milk-sensitive strain of E.coli by immuno-
      globulins and iron-binding proteins associated withColostrum.
      Immunology 35:663-670, 1981.

22. Stephan W, et al: Antibodies from Colostrum in oral immunotherapy.
      J Clin Chem Clin Biochem 28:19-23,1990.

23. Wada N, et al: Neutralizing activity against Clostridium difficiletoxins in the
      supernatants of cultured colostral cells. Infect Immune29:545-550,1980.
 
24. Ferrer-Argote VE; Romero-Cabello R; Hernandez-Mendoza L; Arista-
      Viveros A; and others Successful treatment of severecomplicated measles with
      non- specific transfer factor. Department ofHematology, Hospital General de
      Mexico, DF, Mexico.  In Vivo 1994 Jul-Aug; 8 (4):555-7

25. Rebulla P; Tedesco F; Radillo O; Battaglioli M; and othersInhibition of in
      vitro adherence of antibody-coated red cells to monocytesby the dialyzable
      leukocyte extract. Centro Trasfusionale e di Immunologiadei Trapianti, Ospedale
      Policlinico, Milan, Italy. Transfusion 1991 Mar-Apr; 31(3): 218-21

26. Fazio M; Negri L; Calabrese F; Correggia F; and others
      A new method for the in vitro transfer of delayedhypersensitivity
      by dialysed transfer factor.
      J Nucl Med Allied Sci 1990 Oct-Dec; 34 (4 Suppl): 271-4

27. Fazio M; Calabrese F; Giacomasso S; Meina G; and other
      Transfer in vivo of tuberculin hypersensitivity bysensitized
      lymphocytes. Chair of Medical Oncology, University ofTurin, Italy.
      Panminerva Med 1993 Sep; 35(3): 149-53

28. Mrazova A; Mraz J Transfer factor and its signification forpractice.
      Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1993;36(3): 117-37

29. Sumiyama K; Kobayashi M; Miyashiro E; Koike M
      Combination therapy with transfer factor and high dosestronger neo-
      minophagen C in chronic hepatitis B in children (HBe Agpositive).
      Department of Pediatrics, Wakayama Medical College, Japan.
      Acta Paediatr Jpn 1991 Jun; 33(3): 327-34

30. Snirc J; Mikula I; Pistl J
      The induction of specific protection against Actinobacillus
      pleuropneumoniae infection by specific DLE.
      Department of Microbiology and Immunology, University of
      Veterinary Medicine, Kosice, Slovakia.
      Acta Microbiol Hung 1993; 40(4): 325-33

31. Qi HY; Wan ZF; Su CZ
      Isolation and purification of HSV-1 specific transferfactor
      produced by HSV-1 immunized goat leukocyte dialysate.
      Department of Biochemistry, Fourth Military MedicalUniversity,
      Xian, P.R. China. Acta Virol 1992 May; 36(3): 231-8

32. Fernandez O; Diaz N; Morales E; Toledo J; and others
      Effect of transfer factor on myelosuppression and related
      morbidity induced by chemotherapy in acute leukaemias.
      Hospital Universitario Dr. Carlos J. Finlay, Marianao,Cuba.
      Br J Haematol 1993 Jul; 84(3): 423-7

33. Kirkpatrick CH
      Structural nature and functions of transfer factors.
      Conrad D. Stephenson Laboratory for Research in Immunology,
      National Jewish Center for Immunology and RespiratoryMedicine,
      Denver, Colorado 80206.
      REVIEW ARTICLE: 26 REFS.
      Ann N Y Acad Sci 1993 Jun 23; 685: 362-8

34. Webb Marcus A.
      The Herbal Companion
      The Essential Guide to Using Herbs for Your Health and WellBeing
      Quintet Publishing Press 6 Blundell Street 1997